McGill Journal of Law and Health

  • Home
  • About
  • Submissions
  • Publications
    • Volume 17, issue 1 (17:1, 2025)
    • Volume 16, issue 1 (16:1, 2024)
    • Volume 15, Issue 2 (15:2, 2023)
    • Volume 15, Issue 1 (15:1, 2021)
    • Volume 14, Issue 2 (14:2, 2021)
    • Volume 14, Issue 1 (14:1, 2020)
    • Volume 13, Issue 2 (13:2, 2020)
    • Volume 13, Issue 1 (13:1, 2019)
    • Volume 12, Issue 2 (12:2, 2019)
    • Volume 12, Issue 1 (12:1, 2018)
    • Volume 11, Issue 2 (11:2, 2017)
    • Volume 11, Special Issue (11:1, 2017)
    • Volume 10, Issue 2 (10:2 – 2017)
    • Volume 10, Issue 1 (10:1 – Special Issue 2016)
    • Volume 9, Issue 2 (9:2 – 2016)
    • Volume 9, Issue 1 (9:1 – 2015-16)
    • Volume 8, Issue 2 (8:2 – Special Issue 2015)
    • Volume 8, Issue 1 (8:1 – 2014-15)
    • Volume 7, Issue 2 (7:2 – 2013)
    • Volume 7, Issue 1 (7:1 – Special Issue 2013)
    • Volume 6, Issue 2 (6:2 – 2012)
    • Volume 6, Issue 1 (6:2 – 2012)
    • Volume 5, Issue 2 (5:2 – 2011)
    • Volume 5, Issue 1 (5:1 – 2011)
    • Volume 4, Issue 2 (4:2 – 2011)
    • Volume 4, Issue 1 (4:1 – 2010)
    • Volume 3, Issue 1 (3:1 – 2009)
    • Volume 2, Issue 1 (2:1 – 2008)
    • Volume 1, Issue 1 (1:1 – 2007)
  • The Blog
  • The Podcast
  • Events
  • Our Team
  • Apply Today
  • Contact Us
FR
  • Virtual Health Expansion: Challenges and Changes

    Contributed by Dylan Yan Introduction The COVID-19 pandemic has caused a drastic shift in Canadian healthcare.…

  • Exploring the Potential Discriminatory Effects Arising from the Use of AI in Healthcare

    Contributed by Annelise Harnanan Introduction The Canadian health care sector is increasingly making use of new…

  • Les tentatives du CEPMB de réduire le fardeau du coût élevé des médicaments au Canada

    Contribué par Anita Sengupta Introduction Les prix des médicaments brevetés au Canada sont parmi les plus…

  • A Shot in the Dark: The Legality of Mandatory Immunization

    Contributed by Ian Bernstein Introduction Following the recent approvals of COVID-19 vaccines, it is reasonable to…

  • Litigation and the Opioid Crisis: Purdue’s US Settlement in the Canadian Legal Context

    Contributed by Dylan Yan Introduction On November 24, 2020, the manufacturers of OxyContin, Purdue Pharmaceuticals, settled…

←Previous Page Next Page→
McGill Journal of Law and Health
  • Facebook
  • Instagram
  • LinkedIn

 

Loading Comments...
 

    • Subscribe Subscribed
      • McGill Journal of Law and Health
      • Join 57 other subscribers
      • Already have a WordPress.com account? Log in now.
      • McGill Journal of Law and Health
      • Subscribe Subscribed
      • Sign up
      • Log in
      • Report this content
      • View site in Reader
      • Manage subscriptions
      • Collapse this bar